KNSA
NASDAQ · Biotechnology
Kiniksa Pharmaceuticals Inte
$78.13
+0.89 (+1.15%)
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
-7.0% upside
Low Target
$47.11
Average Target
$72.69
High Target
$100.82
Current Price
$78.13
Current
$78.13
$78.13
Target
$72.69
$72.69
$47.11
$72.69 avg
$100.82
Scenario Analysis
Bear Case
$47.11
-39.7%
Low target
Base Case
$72.69
-7.0%
Avg target
Bull Case
$100.82
+29.0%
High target
Risk/Reward
0.7x
Unfavorable
Price in Context
52-Week High
$82.94
-5.8% from high
52-Week Low
$35.20
+122.0% from low
50-Day SMA
$42.51
+83.8% vs SMA
200-Day SMA
$35.71
+118.8% vs SMA
RSI (14)
68.7
Neutral
Target vs 52W High
$72.69
-12.4% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -2.6% |
| AMGN | Hold | 43 | 47% | $190.87 | -51.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +140.9% |
| VRTX | Strong Buy | 36 | 81% | $438.34 | -14.2% |
| REGN | Buy | 38 | 68% | $76.80 | -90.4% |
| MRNA | Hold | 30 | 37% | $149.45 | -13.6% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -61.4% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -40.8% |